Literature DB >> 14288104

6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID: LIMITATIONS AS A SCREENING TEST FOR GENITAL CANCER.

C B CAMERON, O A HUSAIN.   

Abstract

Keywords:  ADENOCARCINOMA; CARCINOMA, EPIDERMOID; MASS SCREENING; NEOPLASM DIAGNOSIS; NEOPLASM STATISTICS; PHOSPHOGLUCONATE DEHYDROGENASE; UTERINE NEOPLASMS; VAGINAL SMEARS

Mesh:

Substances:

Year:  1965        PMID: 14288104      PMCID: PMC2166754          DOI: 10.1136/bmj.1.5449.1529

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  2 in total

1.  LABORATORY DIAGNOSIS OF EARLY MALIGNANT DISEASE. NEW DIAGNOSTIC TESTS FOR CANCER OF THE UTERUS.

Authors:  D G BONHAM
Journal:  Trans Med Soc Lond       Date:  1964

2.  Detection of Cervical Carcinoma in the General Population.

Authors:  J E Macgregor; D Baird
Journal:  Br Med J       Date:  1963-06-22
  2 in total
  6 in total

1.  Histochemistry of mouse cervical epithelium during chemical carcinogenesis.

Authors:  S L Manocha; C E Graham
Journal:  Histochem J       Date:  1970-09

2.  Diagnostic test for cervical cancer.

Authors:  D M Goldberg; C Watts; D M Hart
Journal:  Br Med J       Date:  1968-02-17

Review 3.  Enzyme assays in malignant disease.

Authors:  C B Cameron
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1970

4.  Cervical screening for carcinoma: a comparison of cytological and enzyme (6-phosphogluconate dehydrogenase) methods and clinical findings.

Authors:  J T Boyd; D F Gibbs; A H Labrum; F R Philps
Journal:  Br Med J       Date:  1967-06-24

5.  A modified tetrazolium reaction for identifying malignant cells from gastric and colonic cancer.

Authors:  K S Ibrahim; O A Husain; L Bitensky; J Chayen
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

6.  Enzymes of the human cervix uteri. Comparison of dehydrogenases of lactate, isocitrate, and phosphogluconate in malignant and non-malignant tissue samples.

Authors:  H A Ayre; D M Goldberg
Journal:  Br J Cancer       Date:  1966-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.